Literature DB >> 18804494

BRCA1 is regulated by Chk2 in response to spindle damage.

Corinne Chabalier-Taste1, Carine Racca, Christine Dozier, Florence Larminat.   

Abstract

Inherited mutations of the breast cancer susceptibility gene 1 (BRCA1) confer an increased risk for breast, ovarian and prostate cancer. BRCA1 has been involved in regulation of cell cycle progression, DNA damage signaling and repair, maintenance of genome integrity, ubiquitination and regulation of transcription. Aside from its essential functions in the DNA damage response BRCA1 has been also involved in the cellular response to microtubule damage. Emerging evidence indicates that BRCA1 regulates the duplication and the function of centrosomes, participates in mitotic spindle assembly and is required in the spindle checkpoint. Given BRCA1 distinct functions in microtubule-dependent pathways, we hypothesized that BRCA1 might be regulated following microtubule damage. In the present study, we report the novel finding that BRCA1 is phosphorylated by the checkpoint kinase Chk2 on the previously identified site Ser988 following anti-mitotic treatment in human cancer cells. Ser988-phosphorylated BRCA1 accumulates at centrosomes in response to microtubule damage but Ser988 is not essential for BRCA1 localization at the microtubule-organizing centers. We further demonstrate that the Ser988 phosphorylation is important for the inhibiting microtubule nucleation activity of BRCA1 and for BRCA1 function in cell survival following microtubule damage. These findings reveal a striking outcome of BRCA1 phosphorylation by Chk2 on its role in microtubule-dependent pathways and suggest a fine cross-talk between DNA damage and spindle damage responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18804494     DOI: 10.1016/j.bbamcr.2008.08.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

1.  Damage-induced BRCA1 phosphorylation by Chk2 contributes to the timing of end resection.

Authors:  Balaji Parameswaran; Huai-Chin Chiang; Yunzhe Lu; Julia Coates; Chu-Xia Deng; Richard Baer; Hui-Kuan Lin; Rong Li; Tanya T Paull; Yanfen Hu
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  CCT241533 is a potent and selective inhibitor of CHK2 that potentiates the cytotoxicity of PARP inhibitors.

Authors:  Victoria E Anderson; Michael I Walton; Paul D Eve; Katherine J Boxall; Laurent Antoni; John J Caldwell; Wynne Aherne; Laurence H Pearl; Antony W Oliver; Ian Collins; Michelle D Garrett
Journal:  Cancer Res       Date:  2011-01-15       Impact factor: 12.701

3.  X-ray structures of checkpoint kinase 2 in complex with inhibitors that target its gatekeeper-dependent hydrophobic pocket.

Authors:  George T Lountos; Andrew G Jobson; Joseph E Tropea; Christopher R Self; Guangtao Zhang; Yves Pommier; Robert H Shoemaker; David S Waugh
Journal:  FEBS Lett       Date:  2011-09-07       Impact factor: 4.124

4.  Rad9A is required for G2 decatenation checkpoint and to prevent endoreduplication in response to topoisomerase II inhibition.

Authors:  Deborah A Greer Card; Megan L Sierant; Scott Davey
Journal:  J Biol Chem       Date:  2010-03-21       Impact factor: 5.157

5.  ATM-mediated Mad1 Serine 214 phosphorylation regulates Mad1 dimerization and the spindle assembly checkpoint.

Authors:  Chunying Yang; Jianwei Hao; Dejuan Kong; Xiaoli Cui; Wei Zhang; Haibo Wang; Xiaojing Guo; Shumei Ma; Xiaodong Liu; Peiyu Pu; Bo Xu
Journal:  Carcinogenesis       Date:  2014-04-11       Impact factor: 4.944

6.  Cellular inhibition of checkpoint kinase 2 (Chk2) and potentiation of camptothecins and radiation by the novel Chk2 inhibitor PV1019 [7-nitro-1H-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide].

Authors:  Andrew G Jobson; George T Lountos; Philip L Lorenzi; Jenny Llamas; John Connelly; David Cerna; Joseph E Tropea; Akikazu Onda; Gabriele Zoppoli; Sudhir Kondapaka; Guangtao Zhang; Natasha J Caplen; John H Cardellina; Stephen S Yoo; Anne Monks; Christopher Self; David S Waugh; Robert H Shoemaker; Yves Pommier
Journal:  J Pharmacol Exp Ther       Date:  2009-09-09       Impact factor: 4.030

7.  Elevated cyclin G2 expression intersects with DNA damage checkpoint signaling and is required for a potent G2/M checkpoint arrest response to doxorubicin.

Authors:  Maike Zimmermann; Aruni S Arachchige-Don; Michaela S Donaldson; Robert F Dallapiazza; Colleen E Cowan; Mary C Horne
Journal:  J Biol Chem       Date:  2012-05-15       Impact factor: 5.157

8.  Profiling of the BRCA1 transcriptome through microarray and ChIP-chip analysis.

Authors:  Julia J Gorski; Kienan I Savage; Jude M Mulligan; Simon S McDade; Jaine K Blayney; Zhaoping Ge; D Paul Harkin
Journal:  Nucleic Acids Res       Date:  2011-08-31       Impact factor: 16.971

9.  DNA-PKcs activates the Chk2-Brca1 pathway during mitosis to ensure chromosomal stability.

Authors:  Z Shang; L Yu; Y-F Lin; S Matsunaga; C-Y Shen; B P C Chen
Journal:  Oncogenesis       Date:  2014-02-03       Impact factor: 7.485

10.  WISP-1 contributes to fractionated irradiation-induced radioresistance in esophageal carcinoma cell lines and mice.

Authors:  Wen-Feng Li; Li Zhang; Hai-Ying Li; Si-Si Zheng; Liang Zhao
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.